INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE
The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as lev...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HUANG, Hua HUANG, Cai Gu |
description | The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives.
La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021188809A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021188809A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021188809A13</originalsourceid><addsrcrecordid>eNrjZHDx9PNw9HF08nFVcPMP8g31cQzx9PdT8HdTcFQI9vcJBfOc_f1CHD39PP3cFXxcwxx9nEJDXIP8fRRCHINCghxDXHkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkaGhhYWFgaWjoTFxqgApUi0O</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><source>esp@cenet</source><creator>HUANG, Hua ; HUANG, Cai Gu</creator><creatorcontrib>HUANG, Hua ; HUANG, Cai Gu</creatorcontrib><description>The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives.
La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.</description><language>eng ; fre</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210923&DB=EPODOC&CC=WO&NR=2021188809A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210923&DB=EPODOC&CC=WO&NR=2021188809A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HUANG, Hua</creatorcontrib><creatorcontrib>HUANG, Cai Gu</creatorcontrib><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><description>The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives.
La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDx9PNw9HF08nFVcPMP8g31cQzx9PdT8HdTcFQI9vcJBfOc_f1CHD39PP3cFXxcwxx9nEJDXIP8fRRCHINCghxDXHkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkaGhhYWFgaWjoTFxqgApUi0O</recordid><startdate>20210923</startdate><enddate>20210923</enddate><creator>HUANG, Hua</creator><creator>HUANG, Cai Gu</creator><scope>EVB</scope></search><sort><creationdate>20210923</creationdate><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><author>HUANG, Hua ; HUANG, Cai Gu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021188809A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HUANG, Hua</creatorcontrib><creatorcontrib>HUANG, Cai Gu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HUANG, Hua</au><au>HUANG, Cai Gu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE</title><date>2021-09-23</date><risdate>2021</risdate><abstract>The present invention discloses a liquid pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) active levalbuterol or a salt thereof, such as levalbuterol tartrate; (b) a pharmacologically acceptable preservative; (c) a pharmacologically acceptable stabilizer, (d) a solvent, and optionally (e) other pharmacologically acceptable additives.
La présente invention concerne une préparation pharmaceutique liquide et un procédé d'administration d'une préparation pharmaceutique par nébulisation de la préparation pharmaceutique dans un inhalateur. La préparation pharmaceutique sans propulseur comprend : (a) du lévalbutérol actif ou un sel de celui-ci, tel que le tartrate de lévalbutérol ; (b) un conservateur pharmaceutiquement acceptable ; (c) un stabilisant pharmacologiquement acceptable, (d) un solvant, et éventuellement (e) d'autres additifs pharmacologiquement acceptables.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2021188809A1 |
source | esp@cenet |
subjects | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HUANG,%20Hua&rft.date=2021-09-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021188809A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |